27840666|t|Uncoupling of Vascular Nitric Oxide Synthase Caused by Intermittent Hypoxia
27840666|a|Objective. Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (CIH), is often present in diabetic (DB) patients. Both conditions are associated with endothelial dysfunction and cardiovascular disease. We hypothesized that diabetic endothelial dysfunction is further compromised by CIH. Methods. Adult male diabetic (BKS.Cg-Dock7(m) +/+ Lepr(db) /J) (db/db) mice (10 weeks old) and their heterozygote littermates were subjected to CIH or intermittent air (IA) for 8 weeks. Mice were separated into 4 groups: IA (intermittent air nondiabetic), IH (intermittent hypoxia nondiabetic), IADB (intermittent air diabetic), and IHDB (intermittent hypoxia diabetic) groups. Endothelium -dependent and endothelium -independent relaxation and modulation by basal nitric oxide (NO) were analyzed using wire myograph. Plasma 8-isoprostane, interleukin-6 (IL-6), and asymmetric dimethylarginine (ADMA) were measured using ELISA. Uncoupling of eNOS was measured using dihydroethidium (DHE) staining. Results. Endothelium -dependent vasodilation and basal NO production were significantly impaired in the IH and IADB group compared to IA group but was more pronounced in IHDB group. Levels of 8-isoprostane, IL-6, ADMA, and eNOS uncoupling were â‰ˆ2-fold higher in IH and IADB groups and were further increased in the IHDB group. Conclusion. Endothelial dysfunction is more pronounced in diabetic mice subjected to CIH compared to diabetic or CIH mice alone. Oxidative stress, ADMA, and eNOS uncoupling were exacerbated by CIH in diabetic mice.
27840666	0	10	Uncoupling	T044	C1516897
27840666	14	22	Vascular	T023	C0005847
27840666	23	44	Nitric Oxide Synthase	T116,T126	C0132555
27840666	55	67	Intermittent	T079	C0205267
27840666	68	75	Hypoxia	T046	C0242184
27840666	87	110	Obstructive sleep apnea	T047	C0520679
27840666	112	115	OSA	T047	C0520679
27840666	135	163	chronic intermittent hypoxia	T046	C0242184
27840666	165	168	CIH	T046	C0242184
27840666	191	199	diabetic	T047	C0011847
27840666	201	203	DB	T047	C0011847
27840666	205	213	patients	T101	C0030705
27840666	251	274	endothelial dysfunction	T047	C0856169
27840666	279	301	cardiovascular disease	T047	C0007222
27840666	324	356	diabetic endothelial dysfunction	T047	C0856169
27840666	383	386	CIH	T046	C0242184
27840666	397	407	Adult male	T032	C0086582
27840666	408	416	diabetic	T047	C0011847
27840666	418	458	BKS.Cg-Dock7(m) +/+ Lepr(db) /J) (db/db)	T050	C2986594
27840666	459	463	mice	T015	C0025929
27840666	468	473	weeks	T079	C0439230
27840666	474	477	old	T079	C0580836
27840666	489	501	heterozygote	T032	C0019425
27840666	532	535	CIH	T046	C0242184
27840666	539	555	intermittent air	T121,T197	C3536832
27840666	557	559	IA	T121,T197	C3536832
27840666	567	572	weeks	T079	C0439230
27840666	574	578	Mice	T015	C0025929
27840666	601	607	groups	T078	C0441833
27840666	609	611	IA	T078	C0441833
27840666	613	641	intermittent air nondiabetic	T078	C0441833
27840666	644	646	IH	T078	C0441833
27840666	648	680	intermittent hypoxia nondiabetic	T078	C0441833
27840666	683	687	IADB	T078	C0441833
27840666	689	714	intermittent air diabetic	T078	C0441833
27840666	721	725	IHDB	T078	C0441833
27840666	727	756	intermittent hypoxia diabetic	T078	C0441833
27840666	758	764	groups	T078	C0441833
27840666	766	777	Endothelium	T024	C0014257
27840666	793	804	endothelium	T024	C0014257
27840666	818	828	relaxation	UnknownType	C0678681
27840666	833	843	modulation	UnknownType	C0678672
27840666	847	852	basal	T082	C0205112
27840666	853	865	nitric oxide	T121,T123,T197	C0028128
27840666	867	869	NO	T121,T123,T197	C0028128
27840666	891	904	wire myograph	T074	C0181931
27840666	906	912	Plasma	T031	C0032105
27840666	913	926	8-isoprostane	T109,T130	C0295541
27840666	928	941	interleukin-6	T116,T129	C0021760
27840666	943	947	IL-6	T116,T129	C0021760
27840666	954	981	asymmetric dimethylarginine	T116,T121	C0067385
27840666	983	987	ADMA	T116,T121	C0067385
27840666	1009	1014	ELISA	T059	C0014441
27840666	1016	1026	Uncoupling	T044	C1516897
27840666	1030	1034	eNOS	T116,T126	C0907532
27840666	1054	1069	dihydroethidium	T109,T121	C0644810
27840666	1071	1074	DHE	T109,T121	C0644810
27840666	1076	1084	staining	T059	C0487602
27840666	1095	1106	Endothelium	T024	C0014257
27840666	1118	1130	vasodilation	T042	C0042401
27840666	1135	1140	basal	T082	C0205112
27840666	1141	1143	NO	T121,T123,T197	C0028128
27840666	1144	1154	production	T038	C3714634
27840666	1190	1192	IH	T078	C0441833
27840666	1197	1207	IADB group	T078	C0441833
27840666	1220	1228	IA group	T078	C0441833
27840666	1256	1266	IHDB group	T078	C0441833
27840666	1278	1291	8-isoprostane	T109,T130	C0295541
27840666	1293	1297	IL-6	T116,T129	C0021760
27840666	1299	1303	ADMA	T116,T121	C0067385
27840666	1309	1313	eNOS	T116,T126	C0907532
27840666	1314	1324	uncoupling	T044	C1516897
27840666	1348	1350	IH	T078	C0441833
27840666	1355	1366	IADB groups	T078	C0441833
27840666	1401	1411	IHDB group	T078	C0441833
27840666	1425	1448	Endothelial dysfunction	T047	C0856169
27840666	1471	1479	diabetic	T047	C0011847
27840666	1480	1484	mice	T015	C0025929
27840666	1498	1501	CIH	T046	C0242184
27840666	1514	1522	diabetic	T047	C0011847
27840666	1526	1529	CIH	T046	C0242184
27840666	1530	1534	mice	T015	C0025929
27840666	1542	1558	Oxidative stress	T049	C0242606
27840666	1560	1564	ADMA	T116,T121	C0067385
27840666	1570	1574	eNOS	T116,T126	C0907532
27840666	1575	1585	uncoupling	T044	C1516897
27840666	1591	1602	exacerbated	T080	C1444749
27840666	1606	1609	CIH	T046	C0242184
27840666	1613	1621	diabetic	T047	C0011847
27840666	1622	1626	mice	T015	C0025929